(Shutterstock) (Shutterstock)
brain power

good_news_from_israel_890x1002

Israeli researchers have used brainwaves of humans under strain to control the release of medicine by tiny robots made from shells made of DNA; Israeli-based NRGene is turning its attention to the human genome in order to help diagnose genetic disorders at an early stage, and much more. 

By: Michael Ordman

ISRAEL’S MEDICAL ACHIEVEMENTS

Use your brain to control nanobots

Researchers at Israel’s Bar Ilan University and the IDC in Herzliya have used brainwaves of humans under strain to control the release of medicine by tiny robots made from shells made of DNA. The technique could be used (for example) to treat schizophrenia or depression.
http://www.dailymail.co.uk/sciencetech/article-3759832/Mind-controlled-nanobots-release-drugs-inside-BRAIN-Tiny-machines-help-treat-depression-epilepsy.html

Israelis diagnose genetic disorders

Israeli-based NRGene is the only company in the world to map the genome for bread, pasta and wild emmer wheat. Now it is turning its attention to the human genome in order to help diagnose genetic disorders at an early stage and strive to personalize medications.
www.timesofisrael.com/nrgene-eyes-human-genomes-with-game-changing-tech/

Pain-free bladder treatments

Israeli startup Vensica Medical is developing the ‘VensiCare, a painless needle-free ultrasound catheter system to deliver treatments for overactive bladder, bladder cancer and interstitial cystitis. Vensica has just raised $500,000 for R&D and completion of device design.
http://vensica.com/bladder-treatment-co-vensica-raises-500000-2/
http://www.globes.co.il/en/article-overactive-bladder-treatment-co-vensica-medical-raises-500000-1001140530

First US patients for Chameleon balloon catheter

Israel’s AV Medical had previously completed trials of its unique balloon catheter that allows simultaneous angioplasty and fluid injection. AV Medical has just commenced using Chameleon on patients in the US.
http://www.a-vmedical.com/wp-content/uploads/2016/07/Chameleon-First-US-Cases-7-18-16-PDF.pdf

Tattoo removal laser gets US approval

The US FDA has approved three wavelengths of the PicoWay picosecond laser from Israel’s Syneron Medical. The device successfully removes tattoos of various colors. Recent trials removed 22 tattoos from 15 patients with no side effects.
http://investors.syneron.com/releases?item=320

Monitoring insulin levels

Israel’s DreaMed Diabetes is developing a decision support technology platform called the Advisor to determine optimal patient-specific insulin treatment plans leading to balanced glucose levels in people with diabetes. DreaMed has just raised $3.3 million for development.
http://www.prnewswire.com/news-releases/dreamed-diabetes-raises-33-million-from-norma-investments-and-a-strategic-investor-300303138.html

Rejoining his family after 18 months as a vegetable

The amazing story of how Moti’s family realized that, despite the paralysis from his stroke, Moti was still there. Now he uses the Israeli device Click2Speak to take part in conversations. And he says that he’s happy!

http://www.ezermizion.org/blog/is-he-still-there/

 

Click here for all of this week’s Good News from Israel.